DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Molecular Properties That Define the Activities of Antibiotics in Escherichia coli and Pseudomonas aeruginosa

Abstract

The permeability barrier of Gram-negative cell envelopes is the major obstacle in the discovery and development of new antibiotics. In Gram-negative bacteria, these difficulties are exacerbated by the synergistic interaction between two biochemically distinct phenomena, the low permeability of the outer membrane (OM) and active multidrug efflux. In this study, we used Pseudomonas aeruginosa and Escherichia coli strains with controllable permeability barriers, achieved through hyperporination of the OMs and varied efflux capacities, to evaluate the contributions of each of the barriers to protection from antibacterials. We analyzed antibacterial activities of β-lactams and fluoroquinolones, antibiotics that are optimized for targets in the periplasm and the cytoplasm, respectively, and performed a machine learning-based analysis to identify physicochemical descriptors that best classify their relative potencies. Our results show that the molecular properties selected by active efflux and the OM barriers are different for the two species. Antibiotic activity in P. aeruginosa was better classified by electrostatic and surface area properties, whereas topology, physical properties, and atom or bond counts best capture the behavior in E. coli. In several cases, descriptor values that correspond to active antibiotics also correspond to significant barrier effects, highlighting the synergy between the two barriers where optimizing for onemore » barrier promotes strengthening of the other barrier. Furthermore, both barriers should be considered when optimizing antibiotics for favorable OM permeability, efflux evasion, or both.« less

Authors:
ORCiD logo [1];  [2];  [2]; ORCiD logo [3]; ORCiD logo [2]; ORCiD logo [4]; ORCiD logo [2]
  1. Univ. of Tennessee, Knoxville, TN (United States)
  2. Univ. of Oklahoma, Norman, OK (United States)
  3. Saint Louis Univ. School of Medicine, St. Louis, MO (United States)
  4. Univ. of Tennessee, Knoxville, TN (United States); Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States)
Publication Date:
Research Org.:
Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1459303
Grant/Contract Number:  
AC05-00OR22725
Resource Type:
Accepted Manuscript
Journal Name:
ACS Infectious Diseases
Additional Journal Information:
Journal Volume: 4; Journal Issue: 8; Journal ID: ISSN 2373-8227
Publisher:
American Chemical Society (ACS)
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; antibiotic permeation; Gram-negative bacteria; machine learning; multidrug efflux; outer membrane; physicochemical properties

Citation Formats

Cooper, Sarah J., Krishnamoorthy, Ganesh, Wolloscheck, David, Walker, John K., Rybenkov, Valentin V., Parks, Jerry M., and Zgurskaya, Helen I. Molecular Properties That Define the Activities of Antibiotics in Escherichia coli and Pseudomonas aeruginosa. United States: N. p., 2018. Web. doi:10.1021/acsinfecdis.8b00036.
Cooper, Sarah J., Krishnamoorthy, Ganesh, Wolloscheck, David, Walker, John K., Rybenkov, Valentin V., Parks, Jerry M., & Zgurskaya, Helen I. Molecular Properties That Define the Activities of Antibiotics in Escherichia coli and Pseudomonas aeruginosa. United States. https://doi.org/10.1021/acsinfecdis.8b00036
Cooper, Sarah J., Krishnamoorthy, Ganesh, Wolloscheck, David, Walker, John K., Rybenkov, Valentin V., Parks, Jerry M., and Zgurskaya, Helen I. Mon . "Molecular Properties That Define the Activities of Antibiotics in Escherichia coli and Pseudomonas aeruginosa". United States. https://doi.org/10.1021/acsinfecdis.8b00036. https://www.osti.gov/servlets/purl/1459303.
@article{osti_1459303,
title = {Molecular Properties That Define the Activities of Antibiotics in Escherichia coli and Pseudomonas aeruginosa},
author = {Cooper, Sarah J. and Krishnamoorthy, Ganesh and Wolloscheck, David and Walker, John K. and Rybenkov, Valentin V. and Parks, Jerry M. and Zgurskaya, Helen I.},
abstractNote = {The permeability barrier of Gram-negative cell envelopes is the major obstacle in the discovery and development of new antibiotics. In Gram-negative bacteria, these difficulties are exacerbated by the synergistic interaction between two biochemically distinct phenomena, the low permeability of the outer membrane (OM) and active multidrug efflux. In this study, we used Pseudomonas aeruginosa and Escherichia coli strains with controllable permeability barriers, achieved through hyperporination of the OMs and varied efflux capacities, to evaluate the contributions of each of the barriers to protection from antibacterials. We analyzed antibacterial activities of β-lactams and fluoroquinolones, antibiotics that are optimized for targets in the periplasm and the cytoplasm, respectively, and performed a machine learning-based analysis to identify physicochemical descriptors that best classify their relative potencies. Our results show that the molecular properties selected by active efflux and the OM barriers are different for the two species. Antibiotic activity in P. aeruginosa was better classified by electrostatic and surface area properties, whereas topology, physical properties, and atom or bond counts best capture the behavior in E. coli. In several cases, descriptor values that correspond to active antibiotics also correspond to significant barrier effects, highlighting the synergy between the two barriers where optimizing for one barrier promotes strengthening of the other barrier. Furthermore, both barriers should be considered when optimizing antibiotics for favorable OM permeability, efflux evasion, or both.},
doi = {10.1021/acsinfecdis.8b00036},
journal = {ACS Infectious Diseases},
number = 8,
volume = 4,
place = {United States},
year = {Mon May 14 00:00:00 EDT 2018},
month = {Mon May 14 00:00:00 EDT 2018}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 43 works
Citation information provided by
Web of Science

Figures / Tables:

Figure 1 Figure 1: Scaled MICs (green) and MIC ratios (blue) for antibiotics in P. aeruginosa sorted by antibiotic class and PAO1 MIC from lowest to highest within each class. Values were natural log-transformed and then scaled between 0 and 1. Gray squares indicate MIC ratios that are outside of the measurablemore » range. MICs report on relative potency and MIC ratios report on the dependence of antibiotic activity on efflux, the OM barrier, or both.« less

Save / Share:

Works referenced in this record:

Multidrug Resistance in Bacteria
journal, June 2009


A Gestalt approach to Gram-negative entry
journal, December 2016


Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It
journal, August 2015


The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria
journal, November 2008

  • Pagès, Jean-Marie; James, Chloë E.; Winterhalter, Mathias
  • Nature Reviews Microbiology, Vol. 6, Issue 12
  • DOI: 10.1038/nrmicro1994

Mechanism of antibiotic efflux in Gram negative bacteria
journal, January 2003

  • Zgurskaya, Helen I.
  • Frontiers in Bioscience, Vol. 8, Issue 6
  • DOI: 10.2741/1134

Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria
journal, October 2017


Bifurcation kinetics of drug uptake by Gram-negative bacteria
journal, September 2017


Current Epidemiology and Growing Resistance of Gram-Negative Pathogens
journal, January 2012


Recover the lost art of drug discovery
journal, May 2012


Breaking the permeability barrier of Escherichia coli by controlled hyperporination of the outer membrane.
journal, October 2016

  • Krishnamoorthy, Ganesh; Wolloscheck, David; Weeks, Jon W.
  • Antimicrobial Agents and Chemotherapy
  • DOI: 10.1128/AAC.01882-16

Use of a Genetic Approach To Evaluate the Consequences of Inhibition of Efflux Pumps in Pseudomonas aeruginosa
journal, June 1999

  • Lomovskaya, Olga; Lee, Angela; Hoshino, Kazuki
  • Antimicrobial Agents and Chemotherapy, Vol. 43, Issue 6
  • DOI: 10.1128/AAC.43.6.1340

Multidrug Efflux Pumps: Expression Patterns and Contribution to Antibiotic Resistance in Pseudomonas aeruginosa Biofilms
journal, June 2001

  • De Kievit, Teresa R.; Parkins, Michael D.; Gillis, Richard J.
  • Antimicrobial Agents and Chemotherapy, Vol. 45, Issue 6
  • DOI: 10.1128/AAC.45.6.1761-1770.2001

Full Structure of the Lipopolysaccharide of Pseudomonas aeruginosa Immunotype 5
journal, February 2004


Porins and specific diffusion channels in bacterial outer membranes.
journal, February 1994


Structure, function and regulation of Pseudomonas aeruginosa porins
journal, July 2017

  • Chevalier, Sylvie; Bouffartigues, Emeline; Bodilis, Josselin
  • FEMS Microbiology Reviews, Vol. 41, Issue 5
  • DOI: 10.1093/femsre/fux020

Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli.
journal, January 1996


Identification and characterization of the TolC protein, an outer membrane protein from Escherichia coli.
journal, January 1983


Mechanism and Function of the Outer Membrane Channel TolC in Multidrug Resistance and Physiology of Enterobacteria
journal, January 2011

  • Zgurskaya, Helen I.; Krishnamoorthy, Ganesh; Ntreh, Abigail
  • Frontiers in Microbiology, Vol. 2
  • DOI: 10.3389/fmicb.2011.00189

Multidrug Efflux in Pseudomonas aeruginosa Components, Mechanisms and Clinical Significance
journal, May 2001

  • Poole, Keith; Srikumar, Ramakrishnan
  • Current Topics in Medicinal Chemistry, Vol. 1, Issue 1
  • DOI: 10.2174/1568026013395605

Predictive compound accumulation rules yield a broad-spectrum antibiotic
journal, May 2017

  • Richter, Michelle F.; Drown, Bryon S.; Riley, Andrew P.
  • Nature, Vol. 545, Issue 7654
  • DOI: 10.1038/nature22308

Kinetic Control of Quorum Sensing in Pseudomonas aeruginosa by Multidrug Efflux Pumps
journal, November 2017

  • Wolloscheck, David; Krishnamoorthy, Ganesh; Nguyen, Jennifer
  • ACS Infectious Diseases, Vol. 4, Issue 2
  • DOI: 10.1021/acsinfecdis.7b00160

ampG Gene of Pseudomonas aeruginosa and Its Role in β-Lactamase Expression
journal, November 2010

  • Zhang, Ying; Bao, Qiyu; Gagnon, Luc A.
  • Antimicrobial Agents and Chemotherapy, Vol. 54, Issue 11
  • DOI: 10.1128/AAC.00009-10

Molecular Mechanisms of β-Lactam Resistance Mediated by AmpC Hyperproduction in Pseudomonas aeruginosa Clinical Strains
journal, November 2005


Iterative partial equalization of orbital electronegativity—a rapid access to atomic charges
journal, January 1980


Negative Regulation of the Pseudomonas aeruginosa Outer Membrane Porin OprD Selective for Imipenem and Basic Amino Acids
journal, May 1999

  • Ochs, Martina M.; McCusker, Matthew P.; Bains, Manjeet
  • Antimicrobial Agents and Chemotherapy, Vol. 43, Issue 5
  • DOI: 10.1128/AAC.43.5.1085

ZINC − A Free Database of Commercially Available Compounds for Virtual Screening
journal, December 2004

  • Irwin, John J.; Shoichet, Brian K.
  • Journal of Chemical Information and Modeling, Vol. 45, Issue 1
  • DOI: 10.1021/ci049714+

ZINC: A Free Tool to Discover Chemistry for Biology
journal, June 2012

  • Irwin, John J.; Sterling, Teague; Mysinger, Michael M.
  • Journal of Chemical Information and Modeling, Vol. 52, Issue 7
  • DOI: 10.1021/ci3001277

Prediction of Physicochemical Parameters by Atomic Contributions
journal, August 1999

  • Wildman, Scott A.; Crippen, Gordon M.
  • Journal of Chemical Information and Computer Sciences, Vol. 39, Issue 5
  • DOI: 10.1021/ci990307l

One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
journal, May 2000

  • Datsenko, K. A.; Wanner, B. L.
  • Proceedings of the National Academy of Sciences, Vol. 97, Issue 12, p. 6640-6645
  • DOI: 10.1073/pnas.120163297

Interplay between Drug Efflux and Antioxidants in Escherichia coli Resistance to Antibiotics
journal, December 2010

  • Dhamdhere, Girija; Krishnamoorthy, Ganesh; Zgurskaya, Helen I.
  • Antimicrobial Agents and Chemotherapy, Vol. 54, Issue 12
  • DOI: 10.1128/AAC.00719-10

Works referencing / citing this record:

Molecular Interactions of Carbapenem Antibiotics with the Multidrug Efflux Transporter AcrB of Escherichia coli
journal, January 2020

  • Atzori, Alessio; Malloci, Giuliano; Cardamone, Francesca
  • International Journal of Molecular Sciences, Vol. 21, Issue 3
  • DOI: 10.3390/ijms21030860

Topological index Nclass as a factor determining the antibacterial activity of quinolones against Escherichia coli
journal, September 2019

  • Suay-García, Beatriz; Alemán-López, Pedro; Bueso-Bordils, José I.
  • Future Medicinal Chemistry, Vol. 11, Issue 17
  • DOI: 10.4155/fmc-2019-0073

Permeability barriers of Gram‐negative pathogens
journal, June 2019

  • Zgurskaya, Helen I.; Rybenkov, Valentin V.
  • Annals of the New York Academy of Sciences, Vol. 1459, Issue 1
  • DOI: 10.1111/nyas.14134

Efflux pump inhibitors of clinically relevant multidrug resistant bacteria
journal, April 2019

  • Lamut, Andraž; Peterlin Mašič, Lucija; Kikelj, Danijel
  • Medicinal Research Reviews, Vol. 39, Issue 6
  • DOI: 10.1002/med.21591

Molecular Interactions of Carbapenem Antibiotics with the Multidrug Efflux Transporter AcrB of Escherichia coli
journal, January 2020

  • Atzori, Alessio; Malloci, Giuliano; Cardamone, Francesca
  • International Journal of Molecular Sciences, Vol. 21, Issue 3
  • DOI: 10.3390/ijms21030860

Figures/Tables have been extracted from DOE-funded journal article accepted manuscripts.